Cellarity Closes $121M Series C Financing
- Cellarity, a Somerville, MA-based life sciences company, raised $121M in Series C funding
- The round, which brought total funding raised to date to $274m, was led by Flagship Pioneering with participation from Kyowa Kirin and Hanwha Impact Partners
- The company intends to use the funds to grow its talent base, strengthen its platform, and advance its pipeline toward the clinic
- The company has developed capabilities combining high-resolution data, single-cell technologies, and machine learning to investigate complex disease biology and purposefully design breakthrough medicines
- To create medicines, the company looks beyond individual molecular targets and instead focuses on the whole cell
- The company has developed capabilities to link biology and chemistry with high dimensional, transcriptomic data to design medicines against the cellular signature of the disease
